Literature DB >> 20053547

A cellular perspective on conformational disease: the role of genetic background and proteostasis networks.

Tali Gidalevitz1, Elise A Kikis, Richard I Morimoto.   

Abstract

The inherently error-prone nature of protein biosynthesis and turnover leads to a constant flux of destabilized proteins. Genetic mutations in conformational disease-associated proteins, as well as exposure to acute and chronic proteotoxic stresses, further increase the load of misfolded protein on the proteostasis network. During aging, this leads to enhanced instability of the proteome, failure to buffer destabilizing genetic mutations or polymorphisms, and cellular decline. The combination of cell-type-specific differences in the buffering capacity of the proteostasis network and destabilizing polymorphisms in the genetic background may account for some of the cell-type specificity observed in disease, even when the predominant disease-associated protein is widely expressed. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053547      PMCID: PMC3050498          DOI: 10.1016/j.sbi.2009.11.001

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  77 in total

Review 1.  Molecular chaperones and protein quality control.

Authors:  Bernd Bukau; Jonathan Weissman; Arthur Horwich
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

2.  Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.

Authors:  Alejandro Lloret; Ella Dragileva; Allison Teed; Janice Espinola; Elisa Fossale; Tammy Gillis; Edith Lopez; Richard H Myers; Marcy E MacDonald; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2006-05-10       Impact factor: 6.150

Review 3.  Modulation of neurodegeneration by molecular chaperones.

Authors:  Paul J Muchowski; Jennifer L Wacker
Journal:  Nat Rev Neurosci       Date:  2005-01       Impact factor: 34.870

Review 4.  Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.

Authors:  Stephen C Meredith
Journal:  Ann N Y Acad Sci       Date:  2005-12       Impact factor: 5.691

5.  Death of neuronal clusters contributes to variance of age at onset in Huntington's disease.

Authors:  Branka Cajavec; Hanspeter Herzel; Samuel Bernard
Journal:  Neurogenetics       Date:  2006-01-14       Impact factor: 2.660

6.  Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates.

Authors:  Gen Matsumoto; Aleksandar Stojanovic; Carina I Holmberg; Soojin Kim; Richard I Morimoto
Journal:  J Cell Biol       Date:  2005-10-10       Impact factor: 10.539

7.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.

Authors:  Albena Jordanova; Joy Irobi; Florian P Thomas; Patrick Van Dijck; Kris Meerschaert; Maarten Dewil; Ines Dierick; An Jacobs; Els De Vriendt; Velina Guergueltcheva; Chitharanjan V Rao; Ivailo Tournev; Francisco A A Gondim; Marc D'Hooghe; Veerle Van Gerwen; Patrick Callaerts; Ludo Van Den Bosch; Jean-Pièrre Timmermans; Wim Robberecht; Jan Gettemans; Johan M Thevelein; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Nat Genet       Date:  2006-01-22       Impact factor: 38.330

8.  Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS.

Authors:  T D Heiman-Patterson; J S Deitch; E P Blankenhorn; K L Erwin; M J Perreault; B K Alexander; N Byers; I Toman; G M Alexander
Journal:  J Neurol Sci       Date:  2005-09-15       Impact factor: 3.181

9.  Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress.

Authors:  Adam B Salmon; Shin Murakami; Andrzej Bartke; John Kopchick; Kyoko Yasumura; Richard A Miller
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-02-08       Impact factor: 4.310

10.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

View more
  47 in total

Review 1.  Aging and immune function: molecular mechanisms to interventions.

Authors:  Subramaniam Ponnappan; Usha Ponnappan
Journal:  Antioxid Redox Signal       Date:  2011-01-08       Impact factor: 8.401

2.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

3.  A screenable in vivo assay to study proteostasis networks in Caenorhabditis elegans.

Authors:  Alexandra Segref; Serena Torres; Thorsten Hoppe
Journal:  Genetics       Date:  2011-02-01       Impact factor: 4.562

4.  Dysregulation of the proteasome increases the toxicity of ALS-linked mutant SOD1.

Authors:  Akira Kitamura; Noriko Inada; Hiroshi Kubota; Gen Matsumoto; Masataka Kinjo; Richard I Morimoto; Kazuhiro Nagata
Journal:  Genes Cells       Date:  2014-01-23       Impact factor: 1.891

Review 5.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

6.  Molecular and functional characterization of the only known hemiascomycete ortholog of the carboxyl terminus of Hsc70-interacting protein CHIP in the yeast Yarrowia lipolytica.

Authors:  Céline N Martineau; Marie-Thérèse Le Dall; Ronald Melki; Jean-Marie Beckerich; Mehdi Kabani
Journal:  Cell Stress Chaperones       Date:  2011-10-29       Impact factor: 3.667

7.  Regulating extracellular proteostasis capacity through the unfolded protein response.

Authors:  Joseph C Genereux; R Luke Wiseman
Journal:  Prion       Date:  2015       Impact factor: 3.931

Review 8.  On the design of broad based screening assays to identify potential pharmacological chaperones of protein misfolding diseases.

Authors:  Subhashchandra Naik; Na Zhang; Phillip Gao; Mark T Fisher
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 9.  Protein homeostasis as a therapeutic target for diseases of protein conformation.

Authors:  Barbara Calamini; Richard I Morimoto
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator.

Authors:  V R Villella; S Esposito; E M Bruscia; M Vicinanza; S Cenci; S Guido; M Pettoello-Mantovani; R Carnuccio; M A De Matteis; A Luini; M C Maiuri; V Raia; G Kroemer; L Maiuri
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.